MAM-2201
 | |
| Systematic (IUPAC) name | |
|---|---|
| (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalenyl)-methanone | |
| Clinical data | |
| |
| Identifiers | |
1354631-24-5  | |
| PubChem | CID 66570720 |
| ChemSpider | 28289977 |
| Chemical data | |
| Formula | C25H24FNO |
| 373.462 g/mol | |
|
SMILES
| |
| |
MAM-2201 (4'-methyl-AM-2201, 5"-fluoro-JWH-122) is a drug that presumably acts as a potent agonist for the cannabinoid receptors. It had never previously been reported in the scientific or patent literature, and was first identified by laboratories in the Netherlands and Germany in June 2011 as an ingredient in synthetic cannabis smoking blends.[1][2][3] Like RCS-4 and AB-001, MAM-2201 thus appears to be a novel compound invented by "research chemical" suppliers specifically for grey-market recreational use. Structurally, MAM-2201 is a hybrid of two known cannabinoid compounds JWH-122 and AM-2201, both of which had previously been used as active ingredients in synthetic cannabis blends before being banned in many countries. MAM-2201 has been banned by being added to the temporary class drug schedule in New Zealand, effective from 13 July 2012.[4]
References
- ↑ EMCDDA–Europol 2011 Annual Report on the implementation of Council Decision 2005/387/JHA
- ↑ Moosmann, B. et al. (2012). "Separation and structural characterization of the synthetic cannabinoids JWH-412 and 1-(5-fluoropentyl)-1H-indol-3yl]-(4-methylnaphthalen-1-yl)methanone using GC–MS, NMR analysis and a flash chromatography system". Forensic Science International 220 (1–3): e17–e22. doi:10.1016/j.forsciint.2011.12.010. PMID 22264627.
- ↑ Simolka, K. et al. (2012). "Analysis of synthetic cannabinoids in "spice-like" herbal highs: Snapshot of the German market in summer 2011". Analytical and Bioanalytical Chemistry 404 (1): 157–171. doi:10.1007/s00216-012-6122-4. PMID 22710567.
- ↑ Temporary Class Drug Notice, 5 July 2012. NZ Department of Internal Affairs.